Wegovy Manufacturer Inks Multi-Million Deal For Monthly Obesity Drug

November 4, 2024Posted inBusiness & Finance

Ascendis Pharma and Novo Nordisk sign exclusive global license for TransCon technology, aiming to advance obesity, type 2 diabetes, and cardiovascular treatments.
read more Read More

‘My heart is breaking right now’: Strictly dancer Amy Dowden leaves contest

Bitcoin Can Ignore The Presidential Election As Noise, Says Arthur Hayes

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Name *

Email *

Website

Save my name, email, and website in this browser for the next time I comment.

Pentagon says there’s ‘no verifiable evidence’ of extraterrestrial technology, beings or activity

Posted inTech

Google Loses Yet Another AI Pioneer As Keras Creator Leaves

Posted inTop Stories

New Sri Lankan President’s Party Headed For Big Win In Snap Elections

Posted inTech

Teen Pleads Guilty To Making 375 ‘Swatting’ Calls Across US

Scroll to Top